These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10488770)

  • 21. Impact of HIV type 1 subtype variation on viral RNA quantitation.
    Parekh B; Phillips S; Granade TC; Baggs J; Hu DJ; Respess R
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):133-42. PubMed ID: 10029245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study.
    Rouet F; Foulongne V; Viljoen J; Steegen K; Becquart P; Valéa D; Danaviah S; Segondy M; Verhofstede C; Van de Perre P;
    J Virol Methods; 2010 Feb; 163(2):253-7. PubMed ID: 19837114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Coste J; Montes B; Reynes J; Peeters M; Segarra C; Vendrell JP; Delaporte E; Segondy M
    J Med Virol; 1996 Dec; 50(4):293-302. PubMed ID: 8950685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).
    Amendola A; Bordi L; Angeletti C; Visco-Comandini U; Abbate I; Cappiello G; Budabbus MA; Eljhawi OA; Mehabresh MI; Girardi E; Antinori A; Ippolito G; Capobianchi MR
    J Acquir Immune Defic Syndr; 2002 Dec; 31(5):488-94. PubMed ID: 12473837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of two commercial procedures for quantification of human immunodeficiency virus type 1 RNA with respect to HIV-1 viral subtype and antiviral treatment.
    Schmid I; Arrer E; Hawranek T; Patsch W
    Clin Lab; 2000; 46(7-8):355-60. PubMed ID: 10934582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays.
    Swanson P; Holzmayer V; Huang S; Hay P; Adebiyi A; Rice P; Abravaya K; Thamm S; Devare SG; Hackett J
    J Virol Methods; 2006 Nov; 137(2):184-92. PubMed ID: 16876263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.
    Emery S; Bodrug S; Richardson BA; Giachetti C; Bott MA; Panteleeff D; Jagodzinski LL; Michael NL; Nduati R; Bwayo J; Kreiss JK; Overbaugh J
    J Clin Microbiol; 2000 Jul; 38(7):2688-95. PubMed ID: 10878065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of human immunodeficiency virus viral load testing in Australia.
    Best SJ; Gust AP; Johnson EI; McGavin CH; Dax EM
    J Clin Microbiol; 2000 Nov; 38(11):4015-20. PubMed ID: 11060062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Problems in the interpretation of HIV-1 viral load assays using commercial reagents.
    O'Shea S; Chrystie I; Cranston R; Mullen J; Corbett K; Murphy G; Parry JV; De Ruiter A; Banatvala J
    J Med Virol; 2000 Jun; 61(2):187-94. PubMed ID: 10797373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplicor HIV monitor, NASBA HIV-1 RNA QT and quantiplex HIV RNA version 2.0 viral load assays: a Canadian evaluation.
    Prud'homme IT; Kim JE; Pilon RG; Minkus T; Hawley-Foss N; Cameron W; Rud EW
    J Clin Virol; 1998 Dec; 11(3):189-202. PubMed ID: 9949955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.
    Antunes R; Figueiredo S; Bártolo I; Pinheiro M; Rosado L; Soares I; Lourenço H; Taveira N
    J Clin Microbiol; 2003 Jul; 41(7):3361-7. PubMed ID: 12843094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.
    Yu ML; Chuang WL; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
    J Clin Pathol; 1999 Nov; 52(11):807-11. PubMed ID: 10690168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5.
    Holguín A; Aracil B; Alvarez A; Barros C; Soriano V
    J Clin Microbiol; 2001 May; 39(5):1850-4. PubMed ID: 11326002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa.
    Crump JA; Scott LE; Msuya E; Morrissey AB; Kimaro EE; Shao JF; Stevens WS
    J Virol Methods; 2009 Dec; 162(1-2):218-22. PubMed ID: 19729037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.
    Rouet F; Ekouevi DK; Chaix ML; Burgard M; Inwoley A; Tony TD; Danel C; Anglaret X; Leroy V; Msellati P; Dabis F; Rouzioux C
    J Clin Microbiol; 2005 Jun; 43(6):2709-17. PubMed ID: 15956387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 viral load: comparative evaluation of three commercially available assays in Argentina.
    Hodara V; Monticelli A; Pampuro S; Salomón H; Jauregui Rueda H; Libonatti O
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):107-13. PubMed ID: 9695883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
    Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
    J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5.
    Katsoulidou A; Petrodaskalaki M; Sypsa V; Papachristou E; Anastassopoulou CG; Gargalianos P; Karafoulidou A; Lazanas M; Kordossis T; Andoniadou A; Hatzakis A
    J Virol Methods; 2006 Feb; 131(2):168-74. PubMed ID: 16194575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.
    Drexler JF; de Souza Luna LK; Pedroso C; Pedral-Sampaio DB; Queiroz AT; Brites C; Netto EM; Drosten C
    J Clin Microbiol; 2007 Jun; 45(6):2061-3. PubMed ID: 17392448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.